PARIS score for evaluation of probability of SARS-CoV-2 infection in cancer patients

Control of transmissible diseases as COVID-19 needs a testing and an isolation strategy. The PARIS score developed by Torjdman et al. was aimed at improving patient selection for testing and quarantining but was derived from a general population. We performed a retrospective analysis of the validity...

Descripción completa

Detalles Bibliográficos
Autores principales: Gueuning, Candice, Ameye, Lieveke, Loizidou, Angela, Grigoriu, Bogdan, Meert, Anne-Pascale
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9178543/
https://www.ncbi.nlm.nih.gov/pubmed/35678883
http://dx.doi.org/10.1007/s00520-022-07199-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9178543/
https://www.ncbi.nlm.nih.gov/pubmed/35678883
http://dx.doi.org/10.1007/s00520-022-07199-9

Ejemplares similares